ImmuPharma PLC
  • Announcements
  • About Us
    • About Us
    • Our Team
    • Board of Directors
  • Our Science
    • Our Science
    • ImmuPharma Biotech
    • Key Clinical Investigators
  • Pipeline
    • Pipeline
    • Autoimmunity & Inflammation
    • Anti-Infectives
  • Partnerships & Collaborations
  • Investors
    • Investors
    • AIM Rule 26 Information
    • Regulatory News
    • Corporate Governance
    • Board of Directors
    • Annual Reports
    • Analyst Research
    • Interviews
    • Professional advisers
    • Email Alerts
  • Contact
Archives
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
December 15, 2015

Over 70 Lupus Specialists Gather in Paris for Lupuzor’s™ Phase III Investigators Meeting

Read More
December 07, 2015

Lupuzor™ Pivotal Phase III Trial Recruiting First US Lupus Patients

Read More
November 04, 2015

Lupuzor™ Phase III Pivotal Trial Update

Read More
October 23, 2015

Board Change

Read More
September 30, 2015

Tim McCarthy Appointed as Non-executive Chairman

Read More
September 30, 2015

Interim Results Announcement for the six months ended 30 June 2015

Read More
July 29, 2015

Richard Warr

Read More
July 27, 2015

ClinicalTrials.Gov registration of LUPUZOR™ Pivotal Phase III Trial

Read More
July 25, 2015

Term Sheet signed with US Investor to secure up to US$14 Million Funding For LUPUZOR™

Read More
June 25, 2015

Lupuzor’s Founder, Dr Slyviane Muller – Awarded Medal of Innovation from CNRS for Lupuzor™

Read More
May 29, 2015

ANNUAL GENERAL MEETING: 2015

Read More
May 07, 2015

Notice of Annual General Meeting: 29 May 2015

Read More
  • 1
  • 2
  • Keep up-to-date with email alerts

  • @immupharma

Aim Rule 26 Contact informationDisclaimerPrivacy PolicySite map

© ImmuPharma PLC 2005-2022 | All rights reserved